Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PCDHGA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C14orf37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRYBB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLYBL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506548 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDSS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CFDP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATRNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRACR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNGA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR155 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHODH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ULBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZMAT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EEFSEC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGAT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MACROD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on